Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Sudeep Pharma Statistics

Total Valuation

Sudeep Pharma has a market cap or net worth of INR 63.35 billion. The enterprise value is 64.25 billion.

Market Cap	63.35B
Enterprise Value	64.25B

Important Dates

The last earnings date was Friday, December 19, 2025.

Earnings Date	Dec 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Sudeep Pharma has 112.95 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	112.95M
Shares Outstanding	112.95M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.92%
Owned by Insiders (%)	37.13%
Owned by Institutions (%)	13.85%
Float	25.44M

Valuation Ratios

The trailing PE ratio is 40.75.

PE Ratio	40.75
Forward PE	n/a
PS Ratio	11.30
PB Ratio	8.58
P/TBV Ratio	9.55
P/FCF Ratio	n/a
P/OCF Ratio	153.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.55, with an EV/FCF ratio of -275.84.

EV / Earnings	42.99
EV / Sales	11.46
EV / EBITDA	32.55
EV / EBIT	34.75
EV / FCF	-275.84

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.19.

Current Ratio	2.64
Quick Ratio	1.31
Debt / Equity	0.19
Debt / EBITDA	0.72
Debt / FCF	-6.13
Interest Coverage	26.92

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	20.13%
Return on Capital Employed (ROCE)	23.59%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	11.68M
Profits Per Employee	3.11M
Employee Count	480
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sudeep Pharma has paid 481.71 million in taxes.

Income Tax	481.71M
Effective Tax Rate	24.19%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	38.42
Average Volume (20 Days)	304,053

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sudeep Pharma had revenue of INR 5.61 billion and earned 1.49 billion in profits. Earnings per share was 13.77.

Revenue	5.61B
Gross Profit	3.57B
Operating Income	1.85B
Pretax Income	1.99B
Net Income	1.49B
EBITDA	1.97B
EBIT	1.85B
Earnings Per Share (EPS)	13.77

Balance Sheet

The company has 676.19 million in cash and 1.43 billion in debt, with a net cash position of -751.02 million or -6.65 per share.

Cash & Cash Equivalents	676.19M
Total Debt	1.43B
Net Cash	-751.02M
Net Cash Per Share	-6.65
Equity (Book Value)	7.39B
Book Value Per Share	66.50
Working Capital	3.35B

Cash Flow

In the last 12 months, operating cash flow was 412.18 million and capital expenditures -645.09 million, giving a free cash flow of -232.92 million.

Operating Cash Flow	412.18M
Capital Expenditures	-645.09M
Free Cash Flow	-232.92M
FCF Per Share	-2.06

Margins

Gross margin is 63.64%, with operating and profit margins of 32.98% and 26.66%.

Gross Margin	63.64%
Operating Margin	32.98%
Pretax Margin	35.51%
Profit Margin	26.66%
EBITDA Margin	35.05%
EBIT Margin	32.98%
FCF Margin	n/a

Dividends & Yields

Sudeep Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	-0.06%
Earnings Yield	2.36%
FCF Yield	-0.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4